Phase II Trial of Sorafenib in Advanced Thyroid Cancer

Journal of Clinical Oncology - United States
doi 10.1200/jco.2008.16.3279
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
1990English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma

Oncologist
Cancer ResearchMedicineOncology
2015English

Randomized, Phase II Trial of Sequential Hepatic Arterial Infusion Chemotherapy and Sorafenib Versus Sorafenib Alone as Initial Therapy for Advanced Hepatocellular Carcinoma: SCOOP-2 Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Phase II Trial of Fenretinide in Advanced Renal Carcinoma

Investigational New Drugs
OncologyPharmacology
2005English

Thymostimulin in Advanced Hepatocellular Carcinoma: A Phase II Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2008English

Phase I/Ii Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients With Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)

Targeted Oncology
Cancer ResearchOncologyPharmacology
2016English

A Phase II Trial of Valproic Acid in Patients With Advanced, Radioiodine-Resistant Thyroid Cancers of Follicular Cell Origin

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2016English

A Phase II Trial of Haptaplatin/5-Fu and Leucovorin for Advanced Stomach Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy